Showing results (51-60 of 3,716) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|October 14, 2020
The novel low molecular weight MYC antagonist MYCMI-6 inhibits proliferation and induces apoptosis in breast cancer cellsDalal AlSultan, Emma Kavanagh, Shane O'Grady, et al.
Investigational New Drugs|December 12, 2019
W941, a new PI3K inhibitor, exhibits preferable anti-proliferative activities against nonsmall cell lung cancer with autophagy inhibitorsDong Liang, Hong-Ying Wang, Shu Fan, et al.
Investigational New Drugs|November 1, 2019
Phase I study of continuous olaparib capsule dosing in combination with carboplatin and/or paclitaxel (Part 1)Ruud van der Noll, Agnes Jager, Joo Ern Ang, et al.
Investigational New Drugs|January 1, 1986
Investigation of the interaction of cardiotoxic anticancer agents using the fetal mouse heart organ culture systemB F Kimler, R D Rethorst, G G Cox
Investigational New Drugs|January 1, 1986
Phase I clinical and pharmacokinetic study of bisantrene in refractory pediatric solid tumorsC B Pratt, J A Sinkule, E Etcubanas, et al.
Investigational New Drugs|January 1, 1986
A phase II study of CHIP in advanced squamous cell carcinoma of the cervix (a Gynecologic Oncology Group Study)W P McGuire, J A Blessing, K Hatch, et al.
Investigational New Drugs|January 1, 1986
Phase II trial of 4'-deoxydoxorubicin (esorubicin) in hormone resistant prostate cancerT Braich, F R Ahmann, H S Garewal, et al.
Investigational New Drugs|August 29, 2020
Serum concentration of the CKD4/6 inhibitor abemaciclib, but not of creatinine, strongly predicts hematological adverse events in patients with breast cancer: a preliminary reportAkimitsu Maeda, Kei Irie, Naoya Hashimoto, et al.
Investigational New Drugs|March 16, 2020
Phase I dose escalation study of BI 836826 (CD37 antibody) in patients with relapsed or refractory B-cell non-Hodgkin lymphomaFrank Kroschinsky, Jan Moritz Middeke, Martin Janz, et al.
Investigational New Drugs|April 1, 1988
In vitro cytotoxicity of pyrazine-2-diazohydroxide: specificity for hypoxic cells and effects of microsomal coincubationJ I Brodfüehrer, D J Moore, D C Melder, et al.
Pageof 372